130 related articles for article (PubMed ID: 8410879)
1. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
Adams ME
J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
[TBL] [Abstract][Full Text] [Related]
2. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
Balazs EA
Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
Pelletier JP; Martel-Pelletier J
J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
[TBL] [Abstract][Full Text] [Related]
4. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial.
Munteanu SE; Zammit GV; Menz HB; Landorf KB; Handley CJ; Elzarka A; Deluca J
Ann Rheum Dis; 2011 Oct; 70(10):1838-41. PubMed ID: 21791454
[TBL] [Abstract][Full Text] [Related]
6. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
8. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
13. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
Yustin D; Kryshtalskyj B; Galea A
J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909
[TBL] [Abstract][Full Text] [Related]
14. The role of viscosupplementation in the ankle using hylan G-F 20.
Carpenter B; Motley T
J Foot Ankle Surg; 2008; 47(5):377-84. PubMed ID: 18725116
[TBL] [Abstract][Full Text] [Related]
15. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.
Adams ME; Lussier AJ; Peyron JG
Drug Saf; 2000 Aug; 23(2):115-30. PubMed ID: 10945374
[TBL] [Abstract][Full Text] [Related]
16. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
Wobig M; Dickhut A; Maier R; Vetter G
Clin Ther; 1998; 20(3):410-23. PubMed ID: 9663358
[TBL] [Abstract][Full Text] [Related]
17. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
[TBL] [Abstract][Full Text] [Related]
18. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
Caborn D; Rush J; Lanzer W; Parenti D; Murray C;
J Rheumatol; 2004 Feb; 31(2):333-43. PubMed ID: 14760806
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
Parenti D; Murray CW
Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
[No Abstract] [Full Text] [Related]
20. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
